Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on June 16, 2025
ASML reports transactions under its current share buyback program
GlobeNewswire
·
June 16, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
June 16, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from June 9, 2025 to June 13, 2025 AMSTERDAM – June 16, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …
Changes in Nokia Corporation's own shares
GlobeNewswire
·
June 16, 2025
Nokia Corporation Stock Exchange Release 16 June 2025 at 15:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 289 221 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia …
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
GlobeNewswire
·
June 16, 2025
Nokia Oyj Pörssitiedote 16.6.2025 klo 15.00 Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 289 221 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin …
MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity
GlobeNewswire
·
June 16, 2025
GLP-1/GIP receptor co-agonist designed to be highly potent and for once-monthly administration based on MBX’s novel PEP™ platform technology Phase 1 trial of MBX 4291 is expected to initiate in Q3 2025 CARMEL, Ind., June 16, 2025 (GLOBE NEWSWIRE) -- MBX …
Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy
GlobeNewswire
·
June 16, 2025
NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced …
SUNation Energy Retains Nasdaq Listing
GlobeNewswire
·
June 16, 2025
RONKONKOMA, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that, by a …
Quantic X-Microwave Launches Newly Enhanced Layout Tool for RF Designers
GlobeNewswire
·
June 16, 2025
AUSTIN, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Quantic X-Microwave®, a business of Quantic Electronics® (“Quantic”) and leading provider of RF …
HII Selected for U.S. Army’s Live Training Contract
GlobeNewswire
·
June 16, 2025
MCLEAN, Va., June 16, 2025 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Mission Technologies division is among the companies included on a multiple award contract to provide live training solutions to the U.S. Army’s Program Executive Office for Simulation, …
X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)
GlobeNewswire
·
June 16, 2025
Poster #1654 highlights clinically meaningful and durable increases in circulating neutrophils observed with mavorixafor treatment +/- G-CSF over 6-month study Poster #1669 highlights findings that investigators were willing and able to reduce injectable G …
Pan American Energy Signs Option Agreement to Acquire 100% Interest in the Tharsis Project, Northwest Territories
GlobeNewswire
·
June 16, 2025
CALGARY, Alberta, June 16, 2025 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (CSE: PNRG | OTC: PAANF | FRA: SS60) (“Pan American” or the “Company”) is pleased to announce that it has entered into a definitive option agreement (the “Agreement”) with …
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
GlobeNewswire
·
June 16, 2025
SAN DIEGO, June 16, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that it will host an in-person and virtual R…
Verizon to report 2Q earnings July 21, 2025
GlobeNewswire
·
June 16, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report second-quarter 2025 earnings on Monday, July 21, 2025. The company will present results on a webcast beginning at 8:30 a.m. Eastern Time. Second-quarter …
Slide Raises $25M Series A led by Base10 Partners to Accelerate Market Growth, Expands to Canada
GlobeNewswire
·
June 16, 2025
NORWALK, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Slide, the next-generation BCDR (Business Continuity and Disaster Recovery) platform purpose-built for MSPs, today announced it has raised $25 million in Series A funding. The round was led by Base10 …
Milestone Pharmaceuticals Submits Response to the FDA’s CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting
GlobeNewswire
·
June 16, 2025
MONTREAL and CHARLOTTE, N.C., June 16, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration (FDA)’s Complete Response Letter (CRL) regarding its New Drug …
Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study
GlobeNewswire
·
June 16, 2025
The Phase 2 Istaroxime study was successful in multiple endpoints showing promise for how it may be utilized if approved in its targeted indications Primary endpoint of the study was met of increasing systolic blood pressure and demonstration of other …
Critical Metals Corp Secures US$120,000,000 LOI for a 15-Year Term Loan From the US Federal Government Bank (EXIM Bank) for the Development of its Tanbreez Rare Earth Project in Greenland
GlobeNewswire
·
June 16, 2025
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that it has received a Letter of Interest from the Export-Import Bank of …
Natural Gas Services Group, Inc. Announces Transition of Stephen C. Taylor to Chairman Emeritus and Appointment of Donald J. Tringali as Chairman of the Board
GlobeNewswire
·
June 16, 2025
Midland, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Natural Gas Services Group, Inc. (NYSE: NGS), a leading provider of natural gas compression equipment, technology, and services to the energy industry, today announced that Stephen C. Taylor has …
Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH
GlobeNewswire
·
June 16, 2025
LungFit PH II’s smaller, lightweight, transport-ready design is expected to open the entirety of the NO market Final design based upon substantial feedback from respiratory therapists across the country GARDEN CITY, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- …
Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025
GlobeNewswire
·
June 16, 2025
CAMBRIDGE, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company outpacing cancer to help patients outlive their disease, today announced that it will host a conference call and live webcast at 8 …